Target Name: MIR1324
NCBI ID: G100302212
Other Name(s): microRNA 1324 | hsa-miR-1324 | hsa-mir-1324 | MicroRNA 1324 | MIRN1324

MIR1324: A Drug Target / Disease Biomarker

MIR1324 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the Mir1 family of genes, which encode for non-coding RNA molecules that have been shown to play important roles in various cellular processes. One of the functions of MIR1324 is to regulate the expression of genes in the brain, and it is thought to be involved in the development and progression of certain neurological conditions.

Recent studies have suggested that MIR1324 may be a drug target or biomarker for a variety of neurological conditions, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. This is because MIR1324 has been shown to be involved in the regulation of the expression of genes that are known to be involved in the development and progression of these conditions.

For example, one study published in the journal Nature Medicine used MIR1324 as a potential drug target for Alzheimer's disease. The researchers found that MIR1324 was highly expressed in the brains of people with Alzheimer's disease, and that they were able to reduce the expression of MIR1324 in the brains of mice by using a small molecule called RNA interference. The researchers then used the mice to test whether reducing MIR1324 expression improved the symptoms of Alzheimer's disease, and they found that it did.

Another study published in the journal PLoS One used MIR1324 as a potential biomarker for Parkinson's disease. The researchers found that MIR1324 was highly expressed in the brains of people with Parkinson's disease, and that they were able to detect MIR1324 levels in the brains of mice using a technique called qRT-PCR. The researchers then used the mice to test whether MIR1324 levels were associated with the symptoms of Parkinson's disease, and they found that MIR1324 levels were higher in the brains of mice with Parkinson's disease than in those without the disease.

These studies suggest that MIR1324 may be an attractive drug target or biomarker for the treatment of neurological conditions, including Alzheimer's disease and Parkinson's disease. Further research is needed to confirm these findings and to develop more effective treatments for these conditions.

Protein Name: MicroRNA 1324

More Common Targets

MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827 | MIR183 | MIR184 | MIR185 | MIR186 | MIR187 | MIR188 | MIR18A | MIR18B | MIR1908 | MIR1909 | MIR190A | MIR190B | MIR191 | MIR1910 | MIR1911 | MIR1912 | MIR1913 | MIR1914 | MIR1915 | MIR1915HG | MIR192 | MIR193A | MIR193B | MIR193BHG | MIR194-1 | MIR194-2 | MIR194-2HG | MIR195 | MIR196A1 | MIR196A2 | MIR196B | MIR197 | MIR1972-1 | MIR1972-2 | MIR1973 | MIR1976 | MIR198 | MIR199A1